Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Kalbe Farma Tbk PT ADR
PTKFYPT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. Address: Gedung KALBE, Jakarta, Indonesia, 10510
Analytics
WallStreetin tavoitehinta
–P/E-suhde
26.5765Osinkotuotto
2.05 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut PTKFY
Osinkoanalytiikka PTKFY
Osinkojen kasvu 5 vuoden aikana
41 %Jatkuva kasvu
3 vuottaMaksusuhde 5 vuoden keskiarvo
7234 %Osinkohistoria PTKFY
Osakkeen arvostus PTKFY
Talousasiat PTKFY
Tuloksia | 2019 | Dynamiikka |